期刊
NEURO-ONCOLOGY
卷 12, 期 7, 页码 756-760出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/noq032
关键词
brain tumor stem cells; glioblastoma; MGMT methylation; temozolomide
资金
- Alberta Heritage Foundation for Medical Research
- Alberta Cancer Foundation
Molecular alterations in glioblastoma have the potential to guide treatment. Here, we explore the relationship between temozolomide (TMZ) response and O-6-methylguanine DNA methyltransferase (MGMT) status in brain tumor initiating cells (BTICs). Methylation, expression, and sensitivity were assessed in 20 lines; associations were evaluated by Fisher's exact test. Some BTICs were sensitive. Sensitivity to TMZ was only associated with protein expression (P = .001). There were atypical BTICs including TMZ-resistant lines in which the methylation-specific PCR reaction revealed both methylated and unmethylated bands. BTICs are not uniformly resistant to TMZ; some are sensitive. MGMT status does not predict TMZ response with high precision.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据